Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma

Oncotarget. 2022 Dec 6:13:1300. doi: 10.18632/oncotarget.28320.
No abstract available

Publication types

  • Published Erratum